Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy with Carbogen and Niacinamide in Bladder Cancer
NCT00033436Phase 3Completed
- Sponsor
- Mount Vernon Cancer Centre
- Start
- Oct 2000
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carbogen, nicotinamide in bladder cancer, sponsored by Mount Vernon Cancer Centre. Started Oct 2000; status: completed.
02
Drugs
carbogennicotinamide
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00033436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033436.